[8] Douketis J, Tosetto A, Marcucci M, et al. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism[J]. Ann Intern Med, 2010,153(8):523-531. DOI: 10.7326/0003-4819-153-8-201010190-00009.

 

[9] Palareti G, Cosmi B, Legnani C, et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study[J]. Blood, 2014,124(2):196-203. DOI: 10.1182/blood-2014-01-548065.

 

[10] Kearon C, Spencer FA, O´Keeffe D, et al. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study[J]. Ann Intern Med, 2015,162(1):27-34. DOI: 10.7326/M14-1275.

 

[11] Bergrem A, Dahm AE, Jacobsen AF, et al. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study[J]. Thromb Haemost, 2012,108(6):1165-1171. DOI: 10.1160/TH12-05-0350.

 

[12] Vormittag R, Simanek R, Ay C, et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study[J]. Arterioscler Thromb Vasc Biol, 2009,29(12):2176-2181. DOI: 10.1161/ATVBAHA.109.190827.

 

[13] Streiff MB, Ye X, Kickler TS, et al. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors[J]. J Neurooncol, 2015,124(2):299-305. DOI: 10.1007/s11060-015-1840-z.

 

[14] Königsbrügge O, Pabinger I, Ay C. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS)[J]. Thromb Res, 2014,133 Suppl 2:S39-43. DOI: 10.1016/S0049-3848(14)50007-2.

 

[15] 中华医学会血液学分会血栓与止血学组. 易栓症诊断中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):982. DOI: 10.3760/cma.j.issn.0253-2727.2012.11.024.